I-5-Bromo-2-Chloro-4′-Ethoxydiphenylmethane CAS 461432-23-5 iDapagliflozin Intermediate Factory

Inkcazelo emfutshane:

Igama: 5-Bromo-2-Chloro-4′-Ethoxydiphenylmethane

Izithethantonye: 4-Bromo-1-Chloro-2-(4-Ethoxybenzyl)benzene

CAS: 461432-23-5

Ubunyulu: ≥99.0% (HPLC)

Imbonakalo: Imhlophe ukuya kwiPael yomgubo weCrystalline oMthubi

Umbindi weDapagliflozin (CAS: 461432-26-8) kunyango lwe-II yeswekile

Umgangatho ophezulu, iMveliso yoRhwebo

Inquiry: alvin@ruifuchem.com


Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ubonelelo lwabavelisi, ubunyulu obuphezulu, iMveliso yoRhwebo
I-Dapagliflozin (CAS: 461432-26-8) IziPhakathi eziNxulumeneyo:
I-5-Bromo-2-Chlorobenzoic Acid CAS 21739-92-4
I-5-Bromo-2-Chloro-4'-Ethoxydiphenylmethane CAS 461432-23-5
2,3,4,6-Tetrakis-O-Trimethylsilyl-D-Gluconolactone CAS 32384-65-9

Iipropati zeMichiza:

Igama leMchiza 5-Bromo-2-Chloro-4'-Ethoxydiphenylmethane
Izithethantonye I-4-Bromo-1-Chloro-2-(4-Ethoxybenzyl)benzene;4-(5-Brom-2-Chlorbenzyl)phenyl-Ethylether;Ukungcola kweDapagliflozin Bromo
Inombolo yeCAS 461432-23-5
Inombolo yeCAT RF-PI447
Ubume beStokhwe Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli I-C15H14BrClO
Ubunzima beMolekyuli 325.63
Indawo yokunyibilika 41.0 ukuba 43.0℃
Uphawu Ruifu Chemical

Iinkcukacha:

Into Iinkcukacha
Imbonakalo Umgubo weCrystalline oMhlophe ukuya kwiPael
Ubunyulu / Indlela yokuHlalutya ≥99.0% (HPLC)
Amanzi (KF) ≤0.50%
Ukungcola ngokupheleleyo ≤1.0%
Umgangatho woVavanyo Umgangatho woShishino
Ukusetyenziswa I-Intermediate ye-Dapagliflozin (CAS: 461432-26-8), uhlobo lwe-II yeswekile

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, Igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.

Izinto eziluncedo:

1

FAQ:

Isicelo:

I-4-Bromo-1-Chloro-2- (4-Ethoxybenzyl)benzene (CAS: 461432-23-5) isetyenziswe njengendawo ephakathi kwi-synthesis ye-Dapagliflozin (CAS: 461432-26-8).I-Dapagliflozin yi-inhibitor enamandla, ekhethiweyo ye-renal sodium-dependent glucose cotransporter 2 (SGLT2) kunyango lwe-2 yeswekile.I-Dapagliflozin lichiza elitsha le-antidiabetic eliphuhliswe ngokudibeneyo yi-Bristol-Myers Squibb kunye ne-AstraZeneca, evunywe yi-Arhente ye-European Medicines Agency (EMA) ngoNovemba 12, 2012. NgoJanuwari 8, 2014, i-US Food and Drug Administration (FDA) iyivumile. ukuba isetyenziswe kunyango lwesifo sikashukela sohlobo lwe-II.

Bhala umyalezo wakho apha kwaye uwuthumele kuthi